Health Care: Drugs

NovaBay Pharmaceuticals Inc (NBY: AMEX)

$0.6497 0.0097 | 1.52%
12/29/15 - 11:20 AM ET
Company Profile
Price and Volume
Recent Price 0.64
52 Week High 1.47
52 Week Low 0.53
Avg. Daily Vol. (Mil) 0.13
Beta (3 year) 0.38
Share Related Items
Mkt Cap (Mil) 33.04
Shares Out (Mil) 51.63
Float (Mil) 43.65
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.00
Current Ratio 4.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 30.79
Price/Book 5.81
Price/Cash Flow -2.30
Per Share Data
Earnings -0.32
Sales 0.02
Book Value 0.11
Cash Flow -0.28
Business Summary
NovaBay Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on addressing the unmet therapeutic needs of the global, topical anti-infective market with its two distinct categories of products, Aganocides and NeutroPhase.
General Information
5980 Horton street
Suite 550
Emeryville, CA 94608
www.novabaypharma.com
Industry : Drugs
Sector: Health Care
Employees: 29
CEO: Dr. Ramin Najafi,PhD
Short Interest
Current Month (Mil) 0.42
Previous Month (Mil) 0.44
Short Interest Ratio (Days) 3.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -134.60
Return on Investments -261.20
Profitability
Gross Margin 99.00
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NBY

Latest NBY Headlines from TheStreet

More Financial News for NBY

Press Releases for NBY

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter